{"DataElement":{"publicId":"6277327","version":"1","preferredName":"Anal Cancer AJCC Edition 8 Group Stage","preferredDefinition":"Stage group based on the combination of T, N, and M categories and relevant prognostic factors for anal carcinoma, using AJCC Ed. 8 criteria.","longName":"ANAL_AJC8_DZ_STG","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"6078358","version":"1","preferredName":"Anal Neoplasm Stage Grouping","preferredDefinition":"A benign or malignant neoplasm that affects the anal canal or anal margin.  Representative examples of benign neoplasms include squamous papilloma and papillary hidradenoma.  Representative examples of malignant neoplasms include carcinoma, lymphoma, and melanoma._An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers.","longName":"6078251v1.0:2230143v1.0","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"6078251","version":"1","preferredName":"Anal Neoplasm","preferredDefinition":"A benign or malignant neoplasm that affects the anal canal or anal margin.  Representative examples of benign neoplasms include squamous papilloma and papillary hidradenoma.  Representative examples of malignant neoplasms include carcinoma, lymphoma, and melanoma.","longName":"C2877","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Anal Neoplasm","conceptCode":"C2877","definition":"A benign or malignant neoplasm that affects the anal canal or anal margin.  Representative examples of benign neoplasms include squamous papilloma and papillary hidradenoma.  Representative examples of malignant neoplasms include carcinoma, lymphoma, and melanoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"65D30DB2-0929-33D4-E053-F662850A5647","latestVersionIndicator":"Yes","beginDate":"2018-02-22","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-02-22","modifiedBy":"ONEDATA","dateModified":"2018-02-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2230143","version":"1","preferredName":"Stage Grouping","preferredDefinition":"Stage Grouping; an assessment based on the combined evaluation of the patient's T stage, M stage, and N stage. (caDSR)","longName":"C38027","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage Grouping","conceptCode":"C38027","definition":"An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F752037A-4CC2-36A8-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-18","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-05-18","modifiedBy":"ONEDATA","dateModified":"2005-05-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"65D369F0-BC4C-1E03-E053-F662850A6AC4","latestVersionIndicator":"Yes","beginDate":"2018-02-22","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-02-22","modifiedBy":"TAYLORT","dateModified":"2018-06-11","changeDescription":"6/11/18 released by tt. 2/22/18 tt created for standardization.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6276578","version":"1","preferredName":"Anal Carcinoma American Joint Committee on Cancer Edition 8 Group Stage","preferredDefinition":"A term that refers to the staging of anal cancer according to the American Joint Committee on Cancer, 8th edition. This staging system applies to all carcinomas arising in the anal canal, including carcinomas that arise within anorectal fistulas and those arising in the perianal area (anal margin). High-grade neuroendocrine carcinomas (small cell neuroendocrine carcinoma and large cell neuroendocrine carcinoma) are staged using this system. There is no AJCC staging system for anal mucosal melanomas and anal well-differentiated neuroendocrine tumors. (from AJCC 8th Ed.)_An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers._The extent of a cancer in the body. Staging is usually based on the size of the tumor, whether lymph nodes contain cancer, and whether the cancer has spread from the original site to other parts of the body.","longName":"6276578v1.0","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"1","maxLength":"4","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"IV","valueDescription":"Stage IV Anal Cancer AJCC v8","ValueMeaning":{"publicId":"6276580","version":"1","preferredName":"Stage IV Anal Cancer AJCC v8","longName":"6276580","preferredDefinition":"Stage IV includes: Any T, Any N, M1. M1: Distant metastasis. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IV Anal Cancer AJCC v8","conceptCode":"C133804","definition":"Stage IV includes: Any T, Any N, M1. M1: Distant metastasis. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6C2E4948-1818-3974-E053-F662850A9303","latestVersionIndicator":"Yes","beginDate":"2018-05-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-05-14","modifiedBy":"ONEDATA","dateModified":"2018-05-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6C2E4948-1831-3974-E053-F662850A9303","beginDate":"2018-05-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-05-14","modifiedBy":"ONEDATA","dateModified":"2018-05-14","deletedIndicator":"No"},{"value":"IIIC","valueDescription":"Stage IIIC Anal Cancer AJCC v8","ValueMeaning":{"publicId":"6276582","version":"1","preferredName":"Stage IIIC Anal Cancer AJCC v8","longName":"6276582","preferredDefinition":"Stage IIIC includes: (T3, N1, M0); (T4, N1, M0). T3: Tumor larger than 5 cm. T4: Tumor of any size invading adjacent organ(s), such as the vagina, urethra, or bladder. N1: Metastasis in inguinal, mesorectal, internal iliac, or external iliac nodes. M0: No distant metastasis. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIIC Anal Cancer AJCC v8","conceptCode":"C133803","definition":"Stage IIIC includes: (T3, N1, M0); (T4, N1, M0). T3: Tumor larger than 5 cm. T4: Tumor of any size invading adjacent organ(s), such as the vagina, urethra, or bladder. N1: Metastasis in inguinal, mesorectal, internal iliac, or external iliac nodes. M0: No distant metastasis. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6C2E4948-183E-3974-E053-F662850A9303","latestVersionIndicator":"Yes","beginDate":"2018-05-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-05-14","modifiedBy":"ONEDATA","dateModified":"2018-05-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6C2E4948-1857-3974-E053-F662850A9303","beginDate":"2018-05-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-05-14","modifiedBy":"ONEDATA","dateModified":"2018-05-14","deletedIndicator":"No"},{"value":"IIIB","valueDescription":"Stage IIIB Anal Cancer AJCC v8","ValueMeaning":{"publicId":"6276584","version":"1","preferredName":"Stage IIIB Anal Cancer AJCC v8","longName":"6276584","preferredDefinition":"Stage IIIB includes: T4, N0, M0. T4: Tumor of any size invading adjacent organ(s), such as the vagina, urethra, or bladder. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIIB Anal Cancer AJCC v8","conceptCode":"C133802","definition":"Stage IIIB includes: T4, N0, M0. T4: Tumor of any size invading adjacent organ(s), such as the vagina, urethra, or bladder. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6C2E4948-1864-3974-E053-F662850A9303","latestVersionIndicator":"Yes","beginDate":"2018-05-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-05-14","modifiedBy":"ONEDATA","dateModified":"2018-05-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6C2E4948-187D-3974-E053-F662850A9303","beginDate":"2018-05-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-05-14","modifiedBy":"ONEDATA","dateModified":"2018-05-14","deletedIndicator":"No"},{"value":"IIIA","valueDescription":"Stage IIIA Anal Cancer AJCC v8","ValueMeaning":{"publicId":"6100728","version":"1","preferredName":"Stage IIIA Anal Cancer AJCC v8","longName":"6100728","preferredDefinition":"Stage IIIA includes: (T1, N1, M0); (T2, N1, M0). T1: Tumor 2 cm or smaller. T2: Tumor larger than 2 cm but equal to or smaller than 5 cm. N1: Metastasis in inguinal, mesorectal, internal iliac, or external iliac nodes. M0: No distant metastasis. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIIA Anal Cancer AJCC v8","conceptCode":"C133801","definition":"Stage IIIA includes: (T1, N1, M0); (T2, N1, M0). T1: Tumor 2 cm or smaller. T2: Tumor larger than 2 cm but equal to or smaller than 5 cm. N1: Metastasis in inguinal, mesorectal, internal iliac, or external iliac nodes. M0: No distant metastasis. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"666EE994-8505-20DC-E053-F662850AB5A8","latestVersionIndicator":"Yes","beginDate":"2018-03-02","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-03-02","modifiedBy":"ONEDATA","dateModified":"2018-03-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6C2E4948-1891-3974-E053-F662850A9303","beginDate":"2018-05-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-05-14","modifiedBy":"ONEDATA","dateModified":"2018-05-14","deletedIndicator":"No"},{"value":"IIB","valueDescription":"Stage IIB Anal Cancer AJCC v8","ValueMeaning":{"publicId":"6276586","version":"1","preferredName":"Stage IIB Anal Cancer AJCC v8","longName":"6276586","preferredDefinition":"Stage IIB includes: T3, N0, M0. T3: Tumor larger than 5 cm. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIB Anal Cancer AJCC v8","conceptCode":"C133799","definition":"Stage IIB includes: T3, N0, M0. T3: Tumor larger than 5 cm. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6C2E4948-189F-3974-E053-F662850A9303","latestVersionIndicator":"Yes","beginDate":"2018-05-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-05-14","modifiedBy":"ONEDATA","dateModified":"2018-05-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6C2E4948-18B8-3974-E053-F662850A9303","beginDate":"2018-05-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-05-14","modifiedBy":"ONEDATA","dateModified":"2018-05-14","deletedIndicator":"No"},{"value":"IIA","valueDescription":"Stage IIA Anal Cancer AJCC v8","ValueMeaning":{"publicId":"6276588","version":"1","preferredName":"Stage IIA Anal Cancer AJCC v8","longName":"6276588","preferredDefinition":"Stage IIA includes: T2, N0, M0. T2: Tumor larger than 2 cm but equal to or smaller than 5 cm. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIA Anal Cancer AJCC v8","conceptCode":"C133798","definition":"Stage IIA includes: T2, N0, M0. T2: Tumor larger than 2 cm but equal to or smaller than 5 cm. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6C2E4948-18C5-3974-E053-F662850A9303","latestVersionIndicator":"Yes","beginDate":"2018-05-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-05-14","modifiedBy":"ONEDATA","dateModified":"2018-05-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6C2E4948-18DE-3974-E053-F662850A9303","beginDate":"2018-05-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-05-14","modifiedBy":"ONEDATA","dateModified":"2018-05-14","deletedIndicator":"No"},{"value":"I","valueDescription":"Stage I Anal Cancer AJCC v8","ValueMeaning":{"publicId":"6276590","version":"1","preferredName":"Stage I Anal Cancer AJCC v8","longName":"6276590","preferredDefinition":"Stage I includes: T1, N0, M0. T1: Tumor 2 cm or smaller. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage I Anal Cancer AJCC v8","conceptCode":"C133796","definition":"Stage I includes: T1, N0, M0. T1: Tumor 2 cm or smaller. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6C2E4948-18EB-3974-E053-F662850A9303","latestVersionIndicator":"Yes","beginDate":"2018-05-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-05-14","modifiedBy":"ONEDATA","dateModified":"2018-05-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6C2E4948-1904-3974-E053-F662850A9303","beginDate":"2018-05-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-05-14","modifiedBy":"ONEDATA","dateModified":"2018-05-14","deletedIndicator":"No"},{"value":"0","valueDescription":"Stage 0 Anal Cancer AJCC v8","ValueMeaning":{"publicId":"6276592","version":"1","preferredName":"Stage 0 Anal Cancer AJCC v8","longName":"6276592","preferredDefinition":"Stage 0 includes: Tis, N0, M0. Tis: High-grade squamous intraepithelial lesion (previously termed carcinoma in situ, Bowen disease, anal intraepithelial neoplasia II-III, high-grade anal intraepithelial neoplasia). N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage 0 Anal Cancer AJCC v8","conceptCode":"C133795","definition":"Stage 0 includes: Tis, N0, M0. Tis: High-grade squamous intraepithelial lesion (previously termed carcinoma in situ, Bowen disease, anal intraepithelial neoplasia II-III, high-grade anal intraepithelial neoplasia). N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6C2E4948-1911-3974-E053-F662850A9303","latestVersionIndicator":"Yes","beginDate":"2018-05-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-05-14","modifiedBy":"ONEDATA","dateModified":"2018-05-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6C2E4948-192A-3974-E053-F662850A9303","beginDate":"2018-05-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-05-14","modifiedBy":"ONEDATA","dateModified":"2018-05-14","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6276577","version":"1","preferredName":"Anal Cancer by AJCC v8 Stage Stage Grouping Stage","preferredDefinition":"A term that refers to the staging of anal cancer according to the American Joint Committee on Cancer, 8th edition. This staging system applies to all carcinomas arising in the anal canal, including carcinomas that arise within anorectal fistulas and those arising in the perianal area (anal margin). High-grade neuroendocrine carcinomas (small cell neuroendocrine carcinoma and large cell neuroendocrine carcinoma) are staged using this system. There is no AJCC staging system for anal mucosal melanomas and anal well-differentiated neuroendocrine tumors. (from AJCC 8th Ed.):An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers.:The extent of a cancer in the body. Staging is usually based on the size of the tumor, whether lymph nodes contain cancer, and whether the cancer has spread from the original site to other parts of the body.","longName":"C133794:C38027:C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Anal Cancer by AJCC v8 Stage","conceptCode":"C133794","definition":"A term that refers to the staging of anal cancer according to the American Joint Committee on Cancer, 8th edition. This staging system applies to all carcinomas arising in the anal canal, including carcinomas that arise within anorectal fistulas and those arising in the perianal area (anal margin). High-grade neuroendocrine carcinomas (small cell neuroendocrine carcinoma and large cell neuroendocrine carcinoma) are staged using this system. There is no AJCC staging system for anal mucosal melanomas and anal well-differentiated neuroendocrine tumors. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Stage Grouping","conceptCode":"C38027","definition":"An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6C2E4948-17EB-3974-E053-F662850A9303","latestVersionIndicator":"Yes","beginDate":"2018-05-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-05-14","modifiedBy":"ONEDATA","dateModified":"2018-05-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"6C2E4948-17FC-3974-E053-F662850A9303","latestVersionIndicator":"Yes","beginDate":"2018-05-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-05-14","modifiedBy":"TAYLORT","dateModified":"2018-06-11","changeDescription":"6/11/18 released by tt. 5/14/18 tt created for standardization.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5574838","version":"1","longName":"Staging/Extent of Disease","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"6005920","version":"1","longName":"AJCC Edition 8","context":"NCI Standards"},{"publicId":"6072202","version":"1","longName":"Anus","context":"NCI Standards"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Disease stage","type":"Preferred Question Text","description":"Disease stage","url":null,"context":"NCI Standards"}],"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"6C2DFBBB-3A73-3C6D-E053-F662850AA3BF","latestVersionIndicator":"Yes","beginDate":"2018-05-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-05-14","modifiedBy":"TAYLORT","dateModified":"2018-06-11","changeDescription":"6/11/18 released by tt. 4/14/18 tt created for standardization.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}